thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q36924445-2A35EF77-481E-42CF-A8D2-3BC474630C52
Q36924445-2A35EF77-481E-42CF-A8D2-3BC474630C52
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36924445-2A35EF77-481E-42CF-A8D2-3BC474630C52
Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer.
P2860
Q36924445-2A35EF77-481E-42CF-A8D2-3BC474630C52
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36924445-2A35EF77-481E-42CF-A8D2-3BC474630C52
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0f92079f97c2b846a3cdca5b2233e814ac5c974f
P2860
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer